Paper40547403
Development of an LC-MS/MS method for quantification of colistin and colistin methanesulfonate in human plasma and its application to stability studies and therapeutic drug monitoring.
Zhao T and 7 others. J Mass Spectrom Adv Clin Lab, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Development of an LC-MS/MS method for quantification of colistin and colistin methanesulfonate in human plasma and its application to stability studies and therapeutic drug monitoring. Papers, record 40547403. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40547403
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Development of an LC-MS/MS method for quantification of colistin and colistin methanesulfonate in human plasma and its application to stability studies and therapeutic drug monitoring.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28011614 | Dosing guidance for intravenous colistin in critically-ill patients. | Clin Infect Dis | 2017 | https://conductscience.org/library/papers/28011614 | PubMed |
| 2 | 30722017 | Population Pharmacokinetics of Intravenous Colistin in Pediatric Patients: Implications for the Selection of Dosage Regimens. | Clin Infect Dis | 2019 | https://conductscience.org/library/papers/30722017 | PubMed |
| 3 | 16723551 | Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 2006 | https://conductscience.org/library/papers/16723551 | PubMed |
| 4 | 1265467 | [Which uric acid value is in need of treatment?]. | Schweiz Med Wochenschr | 1976 | https://conductscience.org/library/papers/1265467 | PubMed |
| 5 | 18606838 | Stability of colistin methanesulfonate in pharmaceutical products and solutions for administration to patients. | Antimicrob Agents Chemother | 2008 | https://conductscience.org/library/papers/18606838 | PubMed |
| 6 | 21238747 | Identification of impurities in polymyxin B and colistin bulk sample using liquid chromatography coupled to mass spectrometry. | Talanta | 2011 | https://conductscience.org/library/papers/21238747 | PubMed |
| 7 | 37776629 | Simple and robust LC-MS/MS method for quantification of colistin methanesulfonate and colistin in human plasma for therapeutic drug monitoring. | J Pharm Biomed Anal | 2023 | https://conductscience.org/library/papers/37776629 | PubMed |
| 8 | 22658626 | Analysis of colistin A and B in fishery products by ultra performance liquid chromatography with positive electrospray ionization tandem mass spectrometry. | J Chromatogr B Analyt Technol Biomed Life Sci | 2012 | https://conductscience.org/library/papers/22658626 | PubMed |
| 9 | 18187372 | Determination of colistin in human plasma, urine and other biological samples using LC-MS/MS. | J Chromatogr B Analyt Technol Biomed Life Sci | 2008 | https://conductscience.org/library/papers/18187372 | PubMed |
| 10 | 25697677 | Colistin, mechanisms and prevalence of resistance. | Curr Med Res Opin | 2015 | https://conductscience.org/library/papers/25697677 | PubMed |
| 11 | 28128096 | Validation of a colistin plasma concentration breakpoint as a predictor of nephrotoxicity in patients treated with colistin methanesulfonate. | Int J Antimicrob Agents | 2016 | https://conductscience.org/library/papers/28128096 | PubMed |
| 12 | 25267662 | New colistin population pharmacokinetic data in critically ill patients suggesting an alternative loading dose rationale. | Antimicrob Agents Chemother | 2014 | https://conductscience.org/library/papers/25267662 | PubMed |
| 13 | 26970986 | Development and validation of a UHPLC-MS/MS assay for colistin methanesulphonate (CMS) and colistin in human plasma and urine using weak-cation exchange solid-phase extraction. | J Pharm Biomed Anal | 2016 | https://conductscience.org/library/papers/26970986 | PubMed |
| 14 | 30299430 | Pharmacokinetic Characteristics and Limited Sampling Strategies for Therapeutic Drug Monitoring of Colistin in Patients With Multidrug-Resistant Gram-Negative Bacterial Infections. | Ther Drug Monit | 2019 | https://conductscience.org/library/papers/30299430 | PubMed |
| 15 | 26729492 | Population Pharmacokinetics of Colistin Methanesulfonate and Colistin in Critically Ill Patients with Acute Renal Failure Requiring Intermittent Hemodialysis. | Antimicrob Agents Chemother | 2016 | https://conductscience.org/library/papers/26729492 | PubMed |
| 16 | 20028824 | Elucidation of the pharmacokinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models. | Antimicrob Agents Chemother | 2010 | https://conductscience.org/library/papers/20028824 | PubMed |
| 17 | 35684427 | HPLC Determination of Colistin in Human Urine Using Alkaline Mobile Phase Combined with Post-Column Derivatization: Validation Using Accuracy Profiles. | Molecules | 2022 | https://conductscience.org/library/papers/35684427 | PubMed |
| 18 | 33782000 | Population Pharmacokinetics and Outcomes of Critically Ill Pediatric Patients Treated with Intravenous Colistin at Higher Than Recommended Doses. | Antimicrob Agents Chemother | 2021 | https://conductscience.org/library/papers/33782000 | PubMed |
| 19 | 18046039 | Compounded colistimethate as possible cause of fatal acute respiratory distress syndrome. | N Engl J Med | 2007 | https://conductscience.org/library/papers/18046039 | PubMed |
| 20 | 19685371 | Nephrotoxicity associated with the use of intravenous colistin. | Scand J Infect Dis | 2009 | https://conductscience.org/library/papers/19685371 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40547403
GET https://conductscience.org/api/papers/v1/40547403/references?page=2